Triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is characterized by the absence of three receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These receptors are not expressed in TNBC, hence the term "triple-negative".
Overview[edit | edit source]
TNBC accounts for approximately 15-20% of all breast cancers. It is more common in women under the age of 40, in African-American women, and in those with a BRCA1 gene mutation. TNBC is often aggressive, with a high recurrence rate and poor prognosis.
Diagnosis[edit | edit source]
Diagnosis of TNBC is made through a biopsy, where a sample of the tumor is examined under a microscope. The absence of ER, PR, and HER2 is confirmed through immunohistochemistry.
Treatment[edit | edit source]
Treatment for TNBC is challenging due to the lack of targeted therapies. The mainstay of treatment is chemotherapy, which can be given before surgery (neoadjuvant) or after surgery (adjuvant). Other treatments may include radiation therapy and surgery.
Prognosis[edit | edit source]
The prognosis for TNBC is generally poorer than for other types of breast cancer, due to the aggressive nature of the disease and the lack of targeted therapies. However, some patients with TNBC have a good response to chemotherapy.
Research[edit | edit source]
Research into new treatments for TNBC is ongoing. Current areas of research include immunotherapy, targeted therapies, and PARP inhibitors.
See also[edit | edit source]
- Breast cancer
- Estrogen receptor
- Progesterone receptor
- Human epidermal growth factor receptor 2
- BRCA1
- Immunohistochemistry
- Chemotherapy
- Radiation therapy
- Surgery
- Immunotherapy
- PARP inhibitors
Triple-negative breast cancer Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Kondreddy Naveen